Pediococcus pentosaceus are coccus shaped microbes, Gram-positive, non-motile, non-spore forming, and are categorized as a "lactic acid bacteria". Pediococcus pentosaceus are able to grow in pH values between 4.5 and 8.0. Pediococcus are unique in that they form tetrads.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Product Information | |
---|---|
Product Overview | Pediococcus pentosaceus are coccus shaped microbes, Gram-positive, non-motile, non-spore forming, and are categorized as a "lactic acid bacteria". Pediococcus pentosaceus are able to grow in pH values between 4.5 and 8.0. Pediococcus are unique in that they form tetrads. |
Target | Pediococcus |
Genus | Pediococcus |
Application | Study and research |
Type Strain | No |
Culture Medium | MRS |
Culture Conditions | 37°C; Facultative anaerobic |
Risk Group | 1 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Pediococcus is a genus of Gram-positive lactic acid bacteria, belonging to the family of Lactobacillacea. The genus Pediococcus consists of the following species: P. acidilactici, P. pentosaceus, P. damnosus, P. parvulus, P. inopinatus, P. halophilus, P. dextrinicus, and P. urinaeequi. Pediococcus spp. cells are spherical and arranged in tetrads. They are facultative anaerobes, non motile and non sporulating. The known pediocins from P. acidilactici, P. pentosaceus and P. damnosus strains are mostly small, hydrophobic proteins. Food application of pediocins can provide a good alternative means in protecting food against foodborne pathogens. Being mild antimicrobials, pediocins are also expected in the future to find more applications in both human and veterinary medicine. P. pentosaceus, a promising strain of lactic acid bacteria; LAB, is gradually attracting attention, leading to a rapid increase in experimental research. |
Alternative Names | Pediococcus pentosaceus; 529 |
The dosage of Pediococcus pentosaceus; 529 varies depending on the experimental model and objectives. Researchers should refer to existing literature and guidelines for specific dosing regimens, often starting with a range of 10^7 to 10^9 CFU per dose.
Pediococcus pentosaceus; 529 can be co-administered with other probiotic strains. When designing combination studies, it is crucial to assess the compatibility and potential synergistic effects between the strains.
Quality control measures include verifying the purity and viability of the bacterial strain, ensuring the absence of contaminants, and validating the strain's identity through genetic or phenotypic methods. Regular monitoring of culture conditions and periodic testing of bacterial performance are recommended.
To maintain viability, Pediococcus pentosaceus; 529 should be handled with care, avoiding prolonged exposure to non-optimal conditions. This includes maintaining appropriate temperature, pH, and anaerobic conditions when necessary. Proper storage and timely use after reconstitution are critical.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.